BlackRock Inc. - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 22 filers reported holding PSYCHEMEDICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2023$307,203
-13.4%
77,381
-0.5%
0.00%
Q2 2023$354,676
-13.6%
77,780
-0.5%
0.00%
Q1 2023$410,440
-3.0%
78,179
-9.4%
0.00%
Q4 2022$423,109
-24.0%
86,266
-0.2%
0.00%
Q3 2022$557,000
+0.9%
86,435
-0.7%
0.00%
Q2 2022$552,000
-9.4%
87,007
-1.6%
0.00%
Q1 2022$609,000
-4.4%
88,416
-2.4%
0.00%
Q4 2021$637,000
-15.3%
90,592
+1.1%
0.00%
Q3 2021$752,000
+20.3%
89,616
+0.0%
0.00%
Q2 2021$625,000
-1.9%
89,613
-12.8%
0.00%
Q1 2021$637,000
+23.4%
102,792
+1.4%
0.00%
Q4 2020$516,000
+14.4%
101,325
-1.0%
0.00%
Q3 2020$451,000
-22.4%
102,358
-2.3%
0.00%
Q2 2020$581,000
-4.4%
104,717
+4.2%
0.00%
Q1 2020$608,000
-33.9%
100,452
-0.1%
0.00%
Q4 2019$920,000
-0.8%
100,503
-1.2%
0.00%
Q3 2019$927,000
-10.0%
101,728
-0.3%
0.00%
Q2 2019$1,030,000
+141.2%
102,074
+235.2%
0.00%
Q1 2019$427,000
-11.4%
30,455
+0.2%
0.00%
Q4 2018$482,000
-14.7%
30,393
+1.0%
0.00%
Q3 2018$565,0000.0%30,092
+2.5%
0.00%
Q2 2018$565,000
-8.7%
29,350
+1.1%
0.00%
Q1 2018$619,000
-1.3%
29,021
-4.9%
0.00%
Q4 2017$627,000
+13.2%
30,528
+1.3%
0.00%
Q3 2017$554,000
-31.5%
30,128
-7.1%
0.00%
Q2 2017$809,000
+43.4%
32,417
+15.1%
0.00%
Q1 2017$564,00028,1600.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 40,001$276,0000.13%
SANTA MONICA PARTNERS LP 20,000$138,0000.10%
Invenomic Capital Management LP 135,631$769,0000.08%
Cannell Capital 78,306$540,0000.08%
RBF Capital, LLC 144,231$996,0000.06%
CRAWFORD INVESTMENT COUNSEL INC 266,502$1,839,0000.04%
Ancora Advisors LLC 80,728$557,0000.01%
HighMark Wealth Management LLC 2,039$14,0000.01%
Renaissance Technologies 341,422$2,356,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 34,618$240,0000.00%
View complete list of PSYCHEMEDICS CORP shareholders